by Hemalatha Rangarajan, MD
Dr. Hemalatha Rangarajan of Nationwide Children’s Hospital (Columbus, Ohio) discusses new CIBMTR findings on pediatric and young adult AML, showing that extramedullary disease (EMD) at...
by Jacob Keller, Chenyu Lin
Cell and gene therapy (CGT) is rapidly transforming modern medicine, requiring scalable infrastructure to support its growing use across cancer and non-malignant diseases. This article highlights...
by Margy MacMillan
Last year, Transplantation and Cellular Therapy, ASTCT’s journal, celebrated its 30th year serving the profession. This milestone caused me to reflect on what the journal has meant to the...
by Sophie Paczesny
Sophie Paczesny, MD, PhD, highlights her work advancing GVHD biomarker research and immunotherapy innovation while sharing her priorities as ASTCT board director of laboratory science. She also...
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Nirali Shah is joined by Dr. Christy Duncan and Dr. Sung‑Yun Pai to talk through recent progress in the field and what it actually takes to deliver these...
by Zahra Mahmoudjafari
Explore expert insights from ASTCT on building scalable, safe CGT (cell and gene therapy) programs, including key infrastructure, operational strategies, and sustainability considerations. This...